Virginie Canel1, Thibault Thubert1, Ingrid Wigniolle1, Hervé Fernandez2, Xavier Deffieux3. 1. Service de Gynécologie Obstétrique et Médecine de la Reproduction, Hôpital Antoine Béclère, APHP, Hôpitaux Universitaires Paris Sud, 157 rue de la Porte-de-Trivaux, 92140, Clamart, France. 2. Service de Gynécologie Obstétrique, Hôpital Bicêtre, APHP, Hôpitaux Universitaires Paris Sud, Le Kremlin Bicetre, 94275, France. 3. Service de Gynécologie Obstétrique et Médecine de la Reproduction, Hôpital Antoine Béclère, APHP, Hôpitaux Universitaires Paris Sud, 157 rue de la Porte-de-Trivaux, 92140, Clamart, France. xavier.deffieux@abc.aphp.fr.
Abstract
INTRODUCTION AND HYPOTHESIS: Placement of a transobturator midurethral sling (MUS) is the standard surgical treatment for stress urinary incontinence. Most recent MUS procedures have been poorly evaluated. We compared the results using a "new" device expected to reduce postoperative pain, the TVT ABBREVO® system (TVT-Abb), with those using the TVT™ obturator system (TVT-O). METHODS: This was a retrospective study comparing the use of the TVT-Abb (in 50 patients) and the TVT-O (in 50 patients). The main outcomes were the amount of postoperative pain, the success rate (no reported urinary leakage and negative cough test) with both MUS procedures, and the prevalence of complications. RESULTS: The mean follow-up time was 12 months. The preoperative characteristics of the two groups were comparable. There was less postoperative pain (VAS, 0 to 100) in the TVT-Abb group than in the TVT-O group (12.2 vs. 24.4, p < 0.01). However, at 6 weeks after surgery there was no significant difference between the two groups (p = 0.32). The incidence of de novo bladder outlet obstruction symptoms was similar in the TVT-Abb group and the TVT-O group (8 % vs. 12 %, p = 0.74). The prevalences of perioperative and postoperative complications (bladder/urethral injury, haemorrhage) in the two groups were equal. The success rates were similar at 12 months after surgery (88 % vs. 78 %, p = 0.29). CONCLUSIONS: The success rates with TVT-Abb and TVT-O were equal at 12 months after surgery, but there was less immediate postoperative pain with TVT-Abb.
INTRODUCTION AND HYPOTHESIS: Placement of a transobturator midurethral sling (MUS) is the standard surgical treatment for stress urinary incontinence. Most recent MUS procedures have been poorly evaluated. We compared the results using a "new" device expected to reduce postoperative pain, the TVT ABBREVO® system (TVT-Abb), with those using the TVT™ obturator system (TVT-O). METHODS: This was a retrospective study comparing the use of the TVT-Abb (in 50 patients) and the TVT-O (in 50 patients). The main outcomes were the amount of postoperative pain, the success rate (no reported urinary leakage and negative cough test) with both MUS procedures, and the prevalence of complications. RESULTS: The mean follow-up time was 12 months. The preoperative characteristics of the two groups were comparable. There was less postoperative pain (VAS, 0 to 100) in the TVT-Abb group than in the TVT-O group (12.2 vs. 24.4, p < 0.01). However, at 6 weeks after surgery there was no significant difference between the two groups (p = 0.32). The incidence of de novo bladder outlet obstruction symptoms was similar in the TVT-Abb group and the TVT-O group (8 % vs. 12 %, p = 0.74). The prevalences of perioperative and postoperative complications (bladder/urethral injury, haemorrhage) in the two groups were equal. The success rates were similar at 12 months after surgery (88 % vs. 78 %, p = 0.29). CONCLUSIONS: The success rates with TVT-Abb and TVT-O were equal at 12 months after surgery, but there was less immediate postoperative pain with TVT-Abb.
Authors: Giovanni A Tommaselli; Carmen Formisano; Costantino Di Carlo; Annamaria Fabozzi; Carmine Nappi Journal: Int Urogynecol J Date: 2012-04-18 Impact factor: 2.894
Authors: Julien Labrie; Bary L C M Berghmans; Kathelijn Fischer; Alfredo L Milani; Ileana van der Wijk; Dina J C Smalbraak; Astrid Vollebregt; René P Schellart; Giuseppe C M Graziosi; J Marinus van der Ploeg; Joseph F G M Brouns; E Stella M Tiersma; Annette G Groenendijk; Piet Scholten; Ben Willem Mol; Elisabeth E Blokhuis; Albert H Adriaanse; Aaltje Schram; Jan-Paul W R Roovers; Antoine L M Lagro-Janssen; Carl H van der Vaart Journal: N Engl J Med Date: 2013-09-19 Impact factor: 91.245
Authors: Bernard T Haylen; Dirk de Ridder; Robert M Freeman; Steven E Swift; Bary Berghmans; Joseph Lee; Ash Monga; Eckhard Petri; Diaa E Rizk; Peter K Sand; Gabriel N Schaer Journal: Int Urogynecol J Date: 2009-11-25 Impact factor: 2.894
Authors: Andrea Braga; Giorgio Caccia; Giovanni Ruggeri; Luca Regusci; Andrea Papadia; Maurizio Serati Journal: Int Urogynecol J Date: 2019-08-28 Impact factor: 2.894
Authors: Marzio Angelo Zullo; Michele Carlo Schiavi; Paolo Luffarelli; Giovanni Prata; Anna Di Pinto; Cosimo Oliva Journal: Int Urogynecol J Date: 2019-08-13 Impact factor: 2.894